OMI240517P24000
- 6.00
- 0.000.00%
Owens & Minor Newsroom
Express News | NYSE Order Imbalance 50245.0 Shares on Buy Side
Here's How Much $1000 Invested In Owens & Minor 5 Years Ago Would Be Worth Today
Owens & Minor (NYSE:OMI) has outperformed the market over the past 5 years by 25.23% on an annualized basis producing an average annual return of 38.3%. Currently, Owens & Minor has a market capitaliz
Research Alert: CFRA Drops Analytical Coverage On Shares Of Owens & Minor, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are dropping analytical coverage on s
Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024
Owens & Minor, Inc. (NYSE:OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and
Owens & Minor Shareholders Endorse Key Proposals and Directors
Owens & Minor Elevates Sarkar to Executive VP & CIO
Express News | NYSE Order Imbalance 58635.0 Shares on Buy Side
Peering Into Owens & Minor's Recent Short Interest
Owens & Minor's (NYSE:OMI) short percent of float has fallen 5.9% since its last report. The company recently reported that it has 5.24 million shares sold short, which is 12.12% of all regular shares
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Owens & Minor (OMI) and Illumina (ILMN)
$1000 Invested In Owens & Minor 5 Years Ago Would Be Worth This Much Today
Owens & Minor (NYSE:OMI) has outperformed the market over the past 5 years by 23.92% on an annualized basis producing an average annual return of 36.22%. Currently, Owens & Minor has a market capitali
Baird Adjusts Owens & Minor Price Target to $24 From $28, Maintains Neutral Rating
Owens & Minor (OMI) has an average rating of Hold and price targets ranging from $18 to $27, according to analysts polled by Capital IQ. Price: 18.40, Change: +0.19, Percent Change: +1.04
Owens & Minor Is Maintained at Neutral by Baird
Owens & Minor Is Maintained at Neutral by Baird
Owens & Minor Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 31.72% Baird $28 → $24 Maintains Neutral 04/30/2024 53.68% Citigroup $24 → $28 Maintains Neutra
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Idexx Laboratories (IDXX) and CytomX Therapeutics (CTMX)
Express News | Owens & Minor Inc : Baird Cuts Target Price to $24 From $28 \
Investor Optimism Improves Slightly Following Jobs Data; Dow Jumps 450 Points
The CNN Money Fear and Greed index showed slight improvement in the overall market sentiment, while the index remained in the "Fear" zone on Friday.U.S. stocks settled higher on Friday, with the Dow J
Owens & Minor Treads Carefully: Navigating Legal Risks in Unregistered Equity Transactions
Benign Growth For Owens & Minor, Inc. (NYSE:OMI) Underpins Stock's 34% Plummet
Owens & Minor, Inc. (NYSE:OMI) shares have had a horrible month, losing 34% after a relatively good period beforehand. The recent drop has obliterated the annual return, with the share price now do
Owens & Minor First Quarter 2024 Earnings: EPS Misses Expectations
Owens & Minor Inc (OMI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...